(Q44680764)

5 December 2017

Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice (English)

1 reference

5 December 2017

0 references

0 references

1 reference

Peter H Yu

1

1 reference

5 December 2017

Michael Wang

2

1 reference

5 December 2017

Hui Fan

3

1 reference

5 December 2017

Yulin Deng

4

1 reference

5 December 2017

Diana Gubisne-Haberle

5

1 reference

5 December 2017

2 December 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

5 December 2017

1 reference

5 December 2017

286

1 reference

5 December 2017

4

1 reference

5 December 2017

E634-41

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

5 December 2017

1 reference

Solubilization and some properties of a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Molecular and metabolic changes in white adipose tissue of the rat during development of ventromedial hypothalamic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Reactive oxygen species activate glucose transport in L6 myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Cardiovascular alterations in dogs treated with hydralazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Obesity: molecular bases of a multifactorial problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Mechanism of stimulation of glucose transport by H2O2: role of phospholipase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Human genomics and obesity: finding appropriate drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Central nervous system control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Adipogenesis and obesity: rounding out the big picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Transgenic GLUT-4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Plasma amine oxidase: a postulated cardiovascular risk factor in nondiabetic obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Physiological and pathological implications of semicarbazide-sensitive amine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00272.2003

10.1152/AJPENDO.00272.2003

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference